Product Description
Overall, the global ENT surgical energy device market was valued at $479.3 million in 2022. This is expected to increase over the forecast period at a CAGR of 1.9% to reach $545.8 million.
The full report suite on the global market for ENT surgical energy device includes capital equipment and radiofrequency (RF) and ultrasonic probes.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL ENT SURGICAL ENERGY DEVICE MARKET INSIGHTS
The major driver for the ENT surgical energy device market is the precision these devices offer during ENT procedures. The precision in the line of demarcation these probes make is so high that many physicians prefer to operate on their patients with these devices.
GLOBAL ENT SURGICAL ENERGY DEVICE MARKET SHARE INSIGHTS
The Global ENT surgical energy device market was controlled by Smith & Nephew, Olympus, and Ethicon.
In 2022, Smith & Nephew led the market for ENT surgical energy devices as the only major player in the market to not offer both RF and ultrasonic energy-based devices. Its flagship product line, Coblation™, uses bipolar RF energy under a conductive medium. Smith & Nephew often gives its generator away for free with the purchase of probes, so its total market share and revenue in this market is mainly generated through its position in the RF and ultrasonic probe segment.
MARKET SEGMENTATION SUMMARY
- ENT Surgical Energy Device Market – MedCore – Includes:
- Capital Equipment, Radiofrequency (RF) and Ultrasonic Probes.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2022 |
| Forecast Period | 2023-2029 |
| Historical Data | 2019-2022 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
